Results 251 to 260 of about 210,777 (318)

The dramatic transition of the extreme Red Supergiant WOH G64 to a Yellow Hypergiant

Munoz-Sanchez G, Kalitsounaki M, de Wit S, Antoniadis K, Bonanos A, Zapartas E, Boutsia K, Christodoulou E, Maravelias G, Soszyński I, Udalski A.   +10 more
europepmc   +1 more source

The Relationship Between Anti-Transgender Experiences (A Proxy for Minority Stress) and Heavy Alcohol Use Among Transgender Adults. [PDF]

Behav Sci (Basel)
Klein H, Washington TA.
europepmc   +1 more source

Dosimetric effect of silicone‐based gel on skin surface during volumetric modulated arc therapy for breast cancer

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose This study aims to quantify and compare the dosimetric effects of varying thicknesses of StrataXRT, a silicone‐based gel, and other topical agents on the skin surface during volumetric modulated arc therapy (VMAT) for breast cancer.
Tenyoh Suzuki, Shingo Ohira, Mami Ogita, Takeshi Ohta, Yuki Nozawa, Masanari Minamitani, Takuya Hayashi, Shigeki Saegusa, Toshikazu Imae, Tsuyoshi Ueyama, Atsuto Katano, Hideomi Yamashita, Weishan Chang, Keiichi Nakagawa   +13 more
wiley   +1 more source

The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma. [PDF]

Brain Commun
Janssen JBE, Brahm CG, Driessen CML, Nuver J, Labots M, Kouwenhoven MCM, Sanchez Aliaga E, Enting RH, de Groot JC, Walenkamp AME, van Linde ME, Verheul HMW.   +11 more
europepmc   +1 more source

Toward a human‐centric co‐design methodology for AI detection of differences between planned and delivered dose in radiotherapy

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Introduction Many artificial intelligence (AI) solutions have been proposed to enhance the radiotherapy (RT) workflow, but limited applications have been implemented to date, suggesting an implementation gap. One contributing factor to this gap is a misalignment between AI systems and their users.
Luca M. Heising, Frank Verhaegen, Stefan G. Scheib, Maria J. G. Jacobs, Carol X. J. Ou, Viola Mottarella, Yin‐Ho Chong, Mariangela Zamburlini, Sebastiaan M. J. J. G. Nijsten, Ans Swinnen, Michel Öllers, Cecile J. A. Wolfs   +11 more
wiley   +1 more source

Open-ended versus bounded evolution: Mineral evolution as a case study. [PDF]

PNAS Nexus
Hazen RM, Wong ML.
europepmc   +1 more source

JACMP 2005–2009

Journal of Applied Clinical Medical Physics, EarlyView.
Timothy D. Solberg
wiley   +1 more source

Facilitating 1.5T MR‐Linac adoption: Workflow strategies and practical tips

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Background MR‐guided radiotherapy (MRgRT) offers new opportunities but also introduces workflow complexities requiring dedicated optimization. Implementing magnetic resonance linear accelerator (MR‐Linac) technology comes with challenges such as prolonged treatment times and workflow integration issues.
Madeline Michel, Zelda Paquier, Christelle Bouchart, Akos Gulyban, Nicolas Jullian, Dirk Van Gestel, Sara Poeta, Nick Reynaert, Philippe Martinive, Robbe Van Den Begin   +9 more
wiley   +1 more source

Quantification and dosimetric impact of intra‐fractional bladder changes during CBCT‐guided online adaptive radiotherapy for pelvic cancer treatments

Journal of Applied Clinical Medical Physics, EarlyView.
Abstract Purpose This study quantitatively evaluates bladder changes and their dosimetric impact during the on‐couch adaptive process on a commercial CBCT‐based online adaptive radiotherapy (CT‐gART) platform. Methods Data from 183 fractions of ten patients receiving online ART for pelvic cancers were analyzed retrospectively.
Ingrid Valencia Lozano, Elizabeth Buss, Catherine S. Spina, David P. Horowitz, Lisa A. Kachnic, Michael Price, Yi‐Fang Wang, Reshma Munbodh   +7 more
wiley   +1 more source

A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer. [PDF]

Front Oncol
Foroughi F, Javadinia SA, Salek R.
europepmc   +1 more source